<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30810672</article-id><article-id pub-id-type="pmc">6385827</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0206</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Potentially Modifiable Predictors for Renal Replacement Therapy in
Patients with Cardiac Surgery Associated-Acute Kidney Injury: a Propensity
Score-Matched Case-Control Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Wuhua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yimei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jiarui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Luo</surname><given-names>Zhe</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Xiaoqiang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0259-8435</contrib-id><name><surname>Teng</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="c1"/><role>MD, PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Department of Nephrology, Zhongshan Hospital, Shanghai Medical
College, Fudan University, Shanghai, China. </aff><aff id="aff2">
<label>2</label> Shanghai Institute of Kidney and Dialysis, Shanghai, China. </aff><aff id="aff3">
<label>3</label> Shanghai Medical Center of Kidney, Shanghai, China. </aff><aff id="aff4">
<label>4</label> Department of Cardiac Surgery Intensive Care Unit, Zhongshan
Hospital, Shanghai Medical College, Fudan University, Shanghai, China. </aff><author-notes><corresp id="c1">Correspondence Address: <bold>Jie Teng</bold>,
http://orcid.org/0000-0003-0598-2149, Department of Nephrology, Zhongshan
Hospital, Shanghai Medical College, Fudan University, No 180 Fenglin Rd,
Shanghai, China - Zip Code: 200032. E-mail:
<email>teng.jie@zsxmhospital.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jan-Feb</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2019</year></pub-date><volume>34</volume><issue>1</issue><fpage>33</fpage><lpage>40</lpage><history><date date-type="received"><day>15</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>14</day><month>8</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To discover potentially modifiable perioperative predictors for renal
replacement therapy (RRT) in patients with cardiac surgery-associated acute
kidney injury (CSA-AKI).</p></sec><sec><title>Methods</title><p>A cohort of 1773 consecutive cardiac surgery patients with postoperative
acute kidney injury (AKI) from January 2013 to December 2015 were included
retrospectively. AKI was defined according to the Kidney Disease: Improving
Global Outcomes (KDIGO) criteria. The primary outcome was CSA-AKI requiring
renal replacement therapy (AKI-RRT). The initiation of RRT was based on
clinical judgment regarding severe volume overload, metabolic abnormality
(<italic>e.g</italic>., acidosis, hyperkalemia), and oliguria. Patients
with AKI-RRT were matched 1:1 with patients without AKI-RRT by a propensity
score, to exclude the influence of patients' demographics, comorbidities,
and baseline renal function. Multivariable regression was performed to
identify the predictors in the matched sample.</p></sec><sec><title>Results</title><p>AKI-RRT occurred in 4.4% of the entire cohort (n=78/1773), with 28.2% of
in-hospital mortality (n=22/78). With the propensity score, 78 pairs of
patients were matched 1:1 and the variables found to be predictors of
AKI-RRT included the contrast exposure within 3 days before surgery (odds
ratio [OR]=2.932), central venous pressure (CVP) &#x0003e;10 mmHg on intensive
care unit (ICU) admission (OR=1.646 per mmHg increase), and erythrocyte
transfusions on the 1<sup>st</sup> day of surgery (OR=1.742 per unit
increase).</p></sec><sec><title>Conclusion</title><p>AKI-RRT is associated with high mortality. The potentially modifiable
predictors found in this study require concern and interventions to prevent
CSA-AKI patients from worsening prognosis.</p></sec></abstract><kwd-group><kwd>Cardiovascular Surgical Procedures</kwd><kwd>Acute Kidney Injury</kwd><kwd>Renal Replacement Therapy</kwd></kwd-group><funding-group><award-group><funding-source>Shanghai Municipal Health Commission</funding-source><award-id>2017ZZ01015</award-id></award-group><award-group><funding-source>Shanghai Shen Kang Hospital Development Center</funding-source><award-id>SHDC12018127</award-id></award-group><award-group><funding-source>Science and Technology Commission of Shanghai
Municipality</funding-source><award-id>14DZ2260200</award-id></award-group><funding-statement>This study is funded by the Shanghai Clinical Medical Center for
Kidney Disease Project support by Shanghai Municipal Health Commission (No.
2017ZZ01015), Shanghai Municipal Hospital Frontier Technology Project supported
by Shanghai ShenKang Hospital Development Center, (SHDC12018127) and the Science
and Technology Commission of Shanghai Municipality (14DZ2260200, the project of
Shanghai Key Laboratory of Kidney and Blood Purification).</funding-statement></funding-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="42%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="42%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AKI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute kidney injury</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">eGFR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Estimated glomerular
filtration rate</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AUC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Area under the
curve</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">GEDVI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Global end-diastolic
volume index</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence interval</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IQR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Interquartile range</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CIN</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Contrast-induced
nephropathy</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">KIDGO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Kidney Disease:
Improving Global Outcomes</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CKD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Chronic kidney
disease</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LCOS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Low cardiac output
syndrome</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CKD-EPI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Chronic Kidney Disease
Epidemiology Collaboration</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NYHA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= New York Heart
Association</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CM</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Contrast media</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">OR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Odds ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RRT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Renal replacement
therapy</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CSA-AKI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiac
surgery-associated acute kidney injury</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SCr</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Serum creatinine</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CVP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Central venous
pressure</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Standard deviation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">DM</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Diabetes mellitus</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">USD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= United States
Dollar</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Acute kidney injury (AKI) is one of the prevalent complications after cardiac
surgery, with reported incidences over 30%, while mortality increases fourfold and
even a slight renal function decrease can influence short- and long-term survival
rates after cardiac surgery<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. However, the patients prone to develop AKI or
severe AKI can be possibly identified. There have been several
studies<sup>[<xref rid="r2" ref-type="bibr">2</xref>-<xref rid="r4" ref-type="bibr">4</xref>]</sup> identifying predictors for cardiac
surgery-associated acute kidney injury (CSA-AKI) or AKI renal replacement therapy
(RRT), including age, gender, preoperative renal function dysfunction, and
comorbidities (<italic>e.g</italic>. hypertension, diabetes mellitus), whereas most
of the predictors are unmodifiable and their clinical significance are limited.
Recently, several modifiable risk factors have been reported participating in the
pathophysiology of CSA-AKI or AKI-RRT<sup>[<xref rid="r5" ref-type="bibr">5</xref>-<xref rid="r9" ref-type="bibr">9</xref>]</sup>. If analyzed along with unmodifiable predictors, the
significance of the modifiable predictors can be concealed due to their lower
occurrence, but their association with worsening renal function will be useful for
prevention, even if AKI will develop inevitably.</p><p>The purpose of this study is to identify the potentially modifiable predictors for
AKI-RRT in CSA-AKI patients, with patients' demographics, preoperative
comorbidities, and preoperative renal function being controlled utilizing propensity
score match.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Patient Sample</title><p>Given the retrospective design of this case-control study, the ethical board
approval from Zhongshan Hospital waived the requirement for informed consent
(Approval No. B2017-039). Data from consecutive patients aged 18 years and older
who underwent specific cardiac surgery and developed CSA-AKI from January 2013
to December 2015 at Zhongshan Hospital were included in the present study.
Inclusion procedures were coronary artery bypass grafting (CABG), valve surgery,
or valve combined with CABG surgery. Patients with previous heart
transplantation, preoperative mechanical ventilation or tracheotomy,
preoperative defibrillator or ventricular assist devices, preoperative RRT,
preoperative liver dysfunction, or sepsis were excluded (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flow diagram outlining the inclusion and exclusion criteria and study
design. AKI=acute kidney injury; CABG=coronary artery bypass
grafting; RRT=renal replacement therapy</p></caption><graphic xlink:href="rbccv-34-01-0033-g01"/></fig></p><p>A propensity score match (1:1) was performed between AKI-RRT patients and
non-AKI-RRT patients to exclude the confounding impact of demographics,
preoperative medical status, and baseline renal function. Covariates included
age, gender, hypertension comorbidities, diabetes mellitus, preoperative
estimated glomerular filtration rate (eGFR), preoperative New York Heart
Association (NYHA) classification, and history of contrast media exposure within
2 weeks before surgery.</p></sec><sec><title>Data Collection</title><p>All perioperative data were collected and extracted retrospectively from the
Zhongshan Hospital's cardiac surgery database. All data were checked twice by
professional personnel before being admitted to the database. Demographic and
perioperative variables known to be related to AKI-RRT were included in this
study after literature review. They included gender, age, comorbidities,
contrast media exposure history, preoperative cardiac function status (NYHA
classification), baseline eGFR (calculated with Chronic Kidney Disease
Epidemiology Collaboration [CKD-EPI] formulae)<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, surgery-related
factors (procedures, urgency, cardiopulmonary bypass [CPB] duration, erythrocyte
transfusion), and post-operative characteristics of central venous pressure
(CVP) and erythrocyte transfusion. Transfusion was performed according to the
clinical guideline, the hemoglobin threshold at which erythrocyte transfusion
was considered was 70 g/L during CPB and 80 g/L after CPB<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. If there were
&#x0003e;1 cardiac surgery procedures performed during the same hospitalization, only
the data on the first surgery were considered. Quality assurance checks of the
data revealed a missing data rate of &#x0003c;2%. Patients with missing values for
variables used in the multivariable analyses were excluded (&#x0003c;1% of the
cases).</p><p>AKI was defined according to the KDIGO guideline<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup> as any of the
following: increase in serum creatinine (SCr) by &#x02265;0.3 mg/dL (&#x02265;26.5
&#x000b5;mol/L) within 48 hours; or increase in SCr to &#x02265;1.5 times baseline
that is known or presumed to have occurred within the prior 7 days; or urine
volume &#x0003c;0.5 mL/kg per hour for 6 hours. The primary outcome was postoperative
AKI requiring RRT (intermittent hemodialysis or continuous venovenous
hemodiafiltration). Consulting nephrologists made decisions about implementing
RRT. Indications for RRT were metabolic abnormalities (acidosis, hyperkalemia),
anuria, and fluid overload.</p></sec><sec><title>Statistical Analyses</title><p>Statistical analyses were performed by SPSS statistics for Windows (Version
24.0., IBM Corp, Armonk, NY, USA). Continuous variables were expressed as
mean&#x000b1;standard deviation (SD) and analyzed by unpaired t-tests, with Welch
adjustment when necessary. Continuous variables that violated the normality
assumption were expressed as median and 25<sup>th</sup> to 75<sup>th</sup>
percentiles and analyzed by a Mann-Whitney U test. Categorical variables were
expressed as absolute (n) and relative (%) frequencies and were analyzed by the
Pearson 2-test or Fisher exact test whenever appropriate. Significant level was
considered with <italic>P</italic>&#x0003c;0.05.</p><p>Univariate analysis was performed in both entire and matched cohorts to identify
the potential risk factors for AKI-RRT. In the 1:1 matched sample, each AKI-RRT
patient was matched to a non-AKI-RRT patient. Covariate balance in the matched
group was assessed with <italic>t</italic>-test and Pearson 2-test or the Fisher
exact test, depending on the property of variables. A stepwise forward logistic
regression was performed afterward to identify the risk factors only with
variables that were significant on univariate analysis
(<italic>P</italic>&#x0003c;0.05). The regression model's goodness of fit was
assessed with the Hosmer-Lemeshow test. Before performing a logistic regression
analysis, the cut-off point was determined for continuous variables on the
receiver operating characteristic curve that had the maximal sum of sensitivity
and specificity. The cut-off points for CPB times were determined in the
previous study<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. The cut-off point for CVP predicting AKI-RRT
was 10 mmHg, with a sensitivity of 68% and a specificity of 60%.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The incidence of AKI-RRT was 4.4 (78/1773) while the in-hospital mortality of the
entire cohort and the RRT cohort was 2.5% (44/1773) and 28.2% (22/78), respectively.
The characteristics of both entire and matched cohorts were presented in <xref rid="t1" ref-type="table">Table 1</xref>. Patients who developed AKI-RRT were
associated with significantly lower preoperative eGFR, higher prevalence of diabetes
mellitus, contrast exposure 3 days before surgery, more significant proportion of
valve &#x00026; CABG procedure, longer CPB time, higher CVP by ICU admittance, and more
erythrocyte transfusion than non-AKI-RRT patients.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Patients' characteristics and perioperative parameters of the AKI-RRT and
non-AKI RRT groups in the entire and matched samples.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">&#x000a0;</th><th align="center" colspan="3" rowspan="1">Entire cohort</th><th align="center" colspan="3" rowspan="1">Matched cohort</th></tr><tr><th align="center" rowspan="1" colspan="1">Non-AKI-RRT (N=1695)</th><th align="center" rowspan="1" colspan="1">AKI-RRT (N=78)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">Non-AKI-RRT (N=78)</th><th align="center" rowspan="1" colspan="1">AKI-RRT (N=78)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" colspan="7" rowspan="1"><bold>Preoperative</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Male, n (%)</td><td align="center" rowspan="1" colspan="1">1104 (65.1)</td><td align="center" rowspan="1" colspan="1">52 (66.7)</td><td align="center" rowspan="1" colspan="1">0.809</td><td align="center" rowspan="1" colspan="1">59 (75.6)</td><td align="center" rowspan="1" colspan="1">52 (66.7)</td><td align="center" rowspan="1" colspan="1">0.216</td></tr><tr><td align="left" rowspan="1" colspan="1">Age, median (IQR), years</td><td align="center" rowspan="1" colspan="1">61 (54,67)</td><td align="center" rowspan="1" colspan="1">62 (54,69)</td><td align="center" rowspan="1" colspan="1">0.217</td><td align="center" rowspan="1" colspan="1">65 (59,70)</td><td align="center" rowspan="1" colspan="1">62 (54,69)</td><td align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" colspan="7" rowspan="1"><bold>Kidney function</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Serum creatinine, median (IQR), mg/dl</td><td align="center" rowspan="1" colspan="1">0.96 (0.8,1.1)</td><td align="center" rowspan="1" colspan="1">1.0 (0.8,1.3)</td><td align="center" rowspan="1" colspan="1">0.152</td><td align="center" rowspan="1" colspan="1">0.9 (0.8,1.2)</td><td align="center" rowspan="1" colspan="1">1.0 (0.8,1.3)</td><td align="center" rowspan="1" colspan="1">0.565</td></tr><tr><td align="left" rowspan="1" colspan="1">eGFR, mean (SD), ml/min/1.73 m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">83.7 (22.8)</td><td align="center" rowspan="1" colspan="1">76.5 (26.9)</td><td align="center" rowspan="1" colspan="1">0.017</td><td align="center" rowspan="1" colspan="1">77.7 (25.3)</td><td align="center" rowspan="1" colspan="1">76.5 (26.9)</td><td align="center" rowspan="1" colspan="1">0.774</td></tr><tr><td align="left" colspan="7" rowspan="1"><bold>Medical history</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, n (%)</td><td align="center" rowspan="1" colspan="1">666 (32.3)</td><td align="center" rowspan="1" colspan="1">38 (48.7)</td><td align="center" rowspan="1" colspan="1">0.096</td><td align="center" rowspan="1" colspan="1">47 (60.3)</td><td align="center" rowspan="1" colspan="1">38 (48.7)</td><td align="center" rowspan="1" colspan="1">0.148</td></tr><tr><td align="left" rowspan="1" colspan="1">DM, n (%)</td><td align="center" rowspan="1" colspan="1">241 (14.2)</td><td align="center" rowspan="1" colspan="1">19 (24.4)</td><td align="center" rowspan="1" colspan="1">0.013</td><td align="center" rowspan="1" colspan="1">21 (26.9)</td><td align="center" rowspan="1" colspan="1">19 (24.4)</td><td align="center" rowspan="1" colspan="1">0.714</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA classification &#x0003e;2, n (%)</td><td align="center" rowspan="1" colspan="1">1128 (66.6)</td><td align="center" rowspan="1" colspan="1">54 (69.2)</td><td align="center" rowspan="1" colspan="1">0.057</td><td align="center" rowspan="1" colspan="1">45 (57.7)</td><td align="center" rowspan="1" colspan="1">54 (69.2)</td><td align="center" rowspan="1" colspan="1">0.135</td></tr><tr><td align="left" rowspan="1" colspan="1">Interval between CM exposure and surgery &#x0003c;3 days, n
(%)</td><td align="center" rowspan="1" colspan="1">52 (3.1)</td><td align="center" rowspan="1" colspan="1">26 (33.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">14 (47.9)</td><td align="center" rowspan="1" colspan="1">26 (33.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="7" rowspan="1"><bold>Laboratory index</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Hemoglobin, mean (SD), g/dL</td><td align="center" rowspan="1" colspan="1">13.19 (16.7)</td><td align="center" rowspan="1" colspan="1">12.89 (19.4)</td><td align="center" rowspan="1" colspan="1">0.243</td><td align="center" rowspan="1" colspan="1">12.95 (21.6)</td><td align="center" rowspan="1" colspan="1">12.89 (19.4)</td><td align="center" rowspan="1" colspan="1">0.675</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin, mean (SD), g/L</td><td align="center" rowspan="1" colspan="1">39.7 (3.4)</td><td align="center" rowspan="1" colspan="1">38.5 (3.6)</td><td align="center" rowspan="1" colspan="1">0.688</td><td align="center" rowspan="1" colspan="1">39.7 (3.3)</td><td align="center" rowspan="1" colspan="1">38.5 (3.6)</td><td align="center" rowspan="1" colspan="1">0.481</td></tr><tr><td align="left" colspan="7" rowspan="1"><bold>Intraoperative</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Valve, n (%)</td><td align="center" rowspan="1" colspan="1">1132 (66.8)</td><td align="center" rowspan="1" colspan="1">49 (62.8)</td><td align="center" rowspan="1" colspan="1">0.468</td><td align="center" rowspan="1" colspan="1">30 (38.5)</td><td align="center" rowspan="1" colspan="1">49 (62.8)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">CABG, n (%)</td><td align="center" rowspan="1" colspan="1">417 (24.6)</td><td align="center" rowspan="1" colspan="1">11 (14.1)</td><td align="center" rowspan="1" colspan="1">0.034</td><td align="center" rowspan="1" colspan="1">31 (39.7)</td><td align="center" rowspan="1" colspan="1">11 (14.1)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Valve &#x00026; CABG, n (%)</td><td align="center" rowspan="1" colspan="1">146 (8.6)</td><td align="center" rowspan="1" colspan="1">18 (23.1)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">17 (21.8)</td><td align="center" rowspan="1" colspan="1">18 (23.1)</td><td align="center" rowspan="1" colspan="1">0.848</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time, mean (SD), min</td><td align="center" rowspan="1" colspan="1">107.7 (38.6)</td><td align="center" rowspan="1" colspan="1">138.6 (52.7)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">111.7 (45.4)</td><td align="center" rowspan="1" colspan="1">138.6 (52.7)</td><td align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" colspan="7" rowspan="1"><bold>Postoperative</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">CVP, median (IQR), mmHg</td><td align="center" rowspan="1" colspan="1">8 (6,10)</td><td align="center" rowspan="1" colspan="1">9 (8,11)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">8 (7,10)</td><td align="center" rowspan="1" colspan="1">9 (8,11)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="TFN2">*</xref>Erythrocyte transfusion, mean (SD)</td><td align="center" rowspan="1" colspan="1">1.1 (1.6)</td><td align="center" rowspan="1" colspan="1">5.1 (4.4)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">0.8 (1.6)</td><td align="center" rowspan="1" colspan="1">5.1 (4.4)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" colspan="7" rowspan="1"><bold>Prognosis</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="TFN3">**</xref>Renal
function complete recovery, n (%)</td><td align="center" rowspan="1" colspan="1">605 (35.7)</td><td align="center" rowspan="1" colspan="1">13 (16.7)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">20 (25.6)</td><td align="center" rowspan="1" colspan="1">13 (16.7)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">In-hospital mortality, n (%)</td><td align="center" rowspan="1" colspan="1">22 (1.3)</td><td align="center" rowspan="1" colspan="1">22 (28.2)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">2 (2.6)</td><td align="center" rowspan="1" colspan="1">22 (28.2)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of hospital stay, median (IQR), days</td><td align="center" rowspan="1" colspan="1">13(11,19)</td><td align="center" rowspan="1" colspan="1">23 (11,47)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">15 (11,19)</td><td align="center" rowspan="1" colspan="1">23 (11,47)</td><td align="center" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">In-hospital expense, median (IQR), USD</td><td align="center" rowspan="1" colspan="1">18522 (15347,22649)</td><td align="center" rowspan="1" colspan="1">34712 (23354,45716)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">14672 (12498,19320)</td><td align="center" rowspan="1" colspan="1">34712 (23354,45716)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>AKI=acute kidney injury; CABG=coronary artery bypass grafting;
CM=contrast media; CPB=cardiopulmonary bypass; CVP=central venous
pressure by intensive care unit admittance; DM=diabetes mellitus;
eGFR=estimated glomerular filtration rate, calculated by Chronic Kidney
Disease Epidemiology Collaboration (CKD-EPI) formulae; IQR=interquartile
range; NYHA=New York Heart Association; RRT=renal replacement therapy;
SD=standard deviation; USD=United States Dollar The values are expressed
as median (IQR), mean (SD), or number (%).</p><p><italic>P</italic>-values are the results of unpaired t-test or
Mann-Whitney U test for continuous variables, and &#x003c7;<sup>2</sup>
test or Fisher's exact test for categorical variables.</p></fn><fn id="TFN2"><label>*</label><p>The amount of erythrocyte transfusion refers to the amount of transfusion
during both intraoperative and postoperative days of surgery.</p></fn><fn id="TFN3"><label>**</label><p>The complete recovery of renal function is defined as a return of
creatinine to no higher than baseline and no dialysis.</p></fn></table-wrap-foot></table-wrap><p>The matched cohort included 78 pairs of patients with and without AKI-RRT. The
logistic regression's goodness of fit in the propensity score-matched model was
assessed fair with the Hosmer-Lemeshow test (&#x003c7;<sup>2</sup>=7.43,
<italic>P</italic>=0.386; <xref ref-type="fig" rid="f2">Figure 2</xref>). As
illustrated by the <italic>P</italic> value of the unpaired <italic>t</italic>-test
or Mann-Whitney test, the groups were well-balanced for the variables, which were
used for covariates to the propensity score. There were no differences in
demographic data, medical history, or preoperative renal function in the matched
sample set.</p><p><fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>The logistic regression's goodness of fit in the propensity score-match
model. &#x003c7;<sup>2</sup>=7.43, P=0.386</p></caption><graphic xlink:href="rbccv-34-01-0033-g02"/></fig></p><p>The result of multivariate logistic regression for AKI-RRT prediction in the matched
cohorts was presented in <xref rid="t2" ref-type="table">Table 2</xref>. Resulted
predictors for AKI-RRT were the exposure of contrast within 3 days before surgery
(odds ratio [OR]=2.932), ICU admission CVP &#x0003e;10 mmHg (OR=1.646 per mmHg increase),
and erythrocyte transfusions on the 1<sup>st</sup> day of surgery (OR=1.742 per unit
increase). Discrimination and calibration of the logistic regression model were
assessed with receiving operating characteristics curve (<xref ref-type="fig" rid="f3">Figure 3</xref>) (area under the curve [AUC]=0.861) and Hosmer-Lemeshow
test (<xref ref-type="fig" rid="f4">Figure 4</xref>) (&#x003c7;<sup>2</sup>=6.08,
<italic>P</italic>=0.638), which indicated an adequate result. AKI-RRT was
related to higher in-hospital mortality, longer length of stay, and higher
in-hospital expense as well (<xref rid="t1" ref-type="table">Table 1</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Multivariate analysis of risk factors for the development of acute kidney
injury in the matched sample.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="60%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Covariate</th><th align="center" rowspan="1" colspan="1">&#x003b2;-coefficient</th><th align="center" rowspan="1" colspan="1">Odds ratio</th><th align="center" rowspan="1" colspan="1">95%CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Interval between preoperative contrast media exposure
&#x0003c;3 days</td><td align="center" rowspan="1" colspan="1">1.076</td><td align="center" rowspan="1" colspan="1">2.932</td><td align="center" rowspan="1" colspan="1">0.951-9.039</td><td align="center" rowspan="1" colspan="1">0.048</td></tr><tr><td align="left" rowspan="1" colspan="1">ICU admission CVP &#x0003e;10 mmHg (per mmHg increase)</td><td align="center" rowspan="1" colspan="1">0.498</td><td align="center" rowspan="1" colspan="1">1.646</td><td align="center" rowspan="1" colspan="1">1.156-2.344</td><td align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">Erythrocyte transfusions (per unit increase)<xref ref-type="table-fn" rid="TFN5">*</xref></td><td align="center" rowspan="1" colspan="1">0.555</td><td align="center" rowspan="1" colspan="1">1.742</td><td align="center" rowspan="1" colspan="1">1.358-2.234</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>CI=confidence interval; CVP=central venous pressure; ICU=intensive care
unit; LCOS=low cardiac output syndrome</p></fn><fn id="TFN5"><label>*</label><p>The amount of erythrocyte transfusion refers to the amount of transfusion
during both intraoperative and postoperative days of surgery.</p></fn></table-wrap-foot></table-wrap><p><fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Discrimination of the logistic regression model for the risk of acute
kidney injury renal replacement therapy (AKI-RRT) in the matched
cohort.</p></caption><graphic xlink:href="rbccv-34-01-0033-g03"/></fig></p><p><fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>The calibration of the logistic regression model for predicting cardiac
surgery-associated acute kidney injury (CSA-AKI) in the matched
cohort.</p></caption><graphic xlink:href="rbccv-34-01-0033-g04"/></fig></p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Although cardiac surgery is booming in developing countries like China, India, and
Brazil, the management of complications, including CSA-AKI, requires more concern.
However, pharmacologic treatment for CSA-AKI remains
controversial<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> and stronger evidence is necessary. To cope with
the CSA-AKI global burden, the identification of risk factors for CSA-AKI or AKI-RRT
has become the priority.</p><p>In many cases, AKI happens inevitably, and the following strategy may encompass AKI's
management, including potential RRT protocol rather than
medications<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Similar to previous studies<sup>[<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r17" ref-type="bibr">17</xref>]</sup>, the mortality, length
of stay, and in-hospital expense of patients who developed AKI-RRT were high in this
cohort. Therefore, identifying the risk of AKI-RRT has become a cardinal problem,
which is related to consulting nephrologists and the following scheme.</p><p>There have been many observational studies focused on the identification of risk
factors in the last decade<sup>[<xref rid="r2" ref-type="bibr">2</xref>-<xref rid="r4" ref-type="bibr">4</xref>]</sup>. These risk factors can be classified as
preoperative, intraoperative, and postoperative. Common risk factors include male
gender, advanced age, and comorbidities (<italic>e.g</italic>. chronic kidney
disease [CKD], diabetes mellitus, hypertension, and cardiac dysfunction). But these
risk factors are readily intuited and non-modifiable and their clinical significance
are limited. Moreover, it's possible that these non-modifiable risk factors could be
concealing the modifiable risk factors. We hypothesized some potentially modifiable
predictors from previous studies<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup> and attenuated the influence of the confounding
patient's demographics and baseline clinical parameters using a propensity
score-matched case-control study.</p><p>Coronary angiography is one of the common preoperative examinations. This procedure
aims to screen the patients with high risk of coronary artery disease and provide
clinicians with multiple cardiac surgery procedure alternatives. A precise
diagnostic method as it is, though, angiography may be risky to susceptible patients
due to contrast-induced nephropathy (CIN). The expected increase of SCr appears
within 48 hours after contrast media exposure, reaching a peak within the following
5 days. Increased morbidity, hospital stay, and mortality are often associated with
CIN<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>.
Few studies were performed to reveal the relationship between contrast media and
CSA-AKI. Not only the incidence of CSA-AKI but both short- and long-term mortalities
as well were found higher in patients who experienced CIN than in those who did
not<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.
Ranucci et al. <sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> found out that surgery on the same day of
angiography significantly increases the risk of AKI. In our study, the interval
between contrast media exposure and cardiac surgery was investigated, and the
cut-off point, which was determined on the receiver operating characteristic curve
that had the maximal sum of sensitivity and specificity, was 3 days. This result was
also significant both in the entire and the matched cohorts. After the logistic
regression, the contrast exposure within 3 days before surgery was one of the
predictors for AKI-RRT. As a modifiable predictor, the interval needs lengthening,
which may reduce the risk of AKI.</p><p>CVP, the downstream pressure of the systemic venous system, is frequently measured in
patients undergoing cardiac surgery. Most of the existing literature focused on the
accuracy of CVP reflecting the right ventricular end-diastolic pressure. Recently,
the importance and role of CVP as a prognostic indicator have also been
studied<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Palomba et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> revealed that the
post-operative CVP was one of the predictors for CSA-AKI. In our study, ICU
admission CVP &#x0003e;10 mmHg was one of the risk factors for AKI-RRT. Increased CVP
implies high renal afterload, while cardiac function recovery delays and the renal
perfusion decreases, which may result in AKI. If available, global end-diastolic
volume index (GEDVI) shall be monitored simultaneously to evaluate the hemodynamics
and renal perfusion. If GEDVI did not increases following CVP, clinicians should be
aware of heart compliance reduction by fluid overload. Hemodynamic parameters,
including CVP, are helpful to evaluate both patients' condition and previous therapy
effect.</p><p>Kidneys receive approximately 20% of the cardiac output and they are highly
susceptible to circulation hypoxia<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. Acute and numerous blood loss is common during
cardiac surgery, and low oxygen delivery is recognized as a risk factor for
developing perioperative AKI. Blood transfusions are frequently performed to improve
oxygen delivery to the kidneys and other vital organs during cardiac surgery and
subsequent ICU stay for ischemic injury prevention. However, previous studies also
indicated a correlation between erythrocyte transfusion and
CSA-AKI<sup>[<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>. The potential harm of erythrocyte transfusion
resulted from both patients and blood storage. Patients who received a massive
amount of erythrocyte transfusion tended to be in a more critical state and to be
more susceptible to hypoxia and CSA-AKI. Besides, it has been reported that the
post-transfusion recovery of red blood cells is lower after a long time of blood
storage<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>. The morphological and biochemical changes during
storage are participating in promoting a pro-inflammatory state, impairing tissue
oxygen delivery, and exacerbating tissue oxidative stress due to free iron, which is
an AKI risk factor for susceptible CPB patients<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>. In our study, the
preoperative hemoglobin level between AKI-RRT patients and non-AKI-RRT patients was
not significant in both the entire and matched cohorts, which indicated a minor
relationship between preoperative hemoglobin and post-operative AKI-RRT. On the
other hand, the erythrocyte transfusion resulted in a modifiable predictor for
AKI-RRT in CSA-AKI patients, and the risk increased along with the amount of
transfusion. Therefore, optimizing the transfusion strategy shall be considered in
the upcoming clinical trials. Several available therapeutic options to reduce the
harm of erythrocyte on CSA-AKI patients were studied<sup>[<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>. Interventions
reducing perioperative hemodilution by minimizing fluid administration and
retrograde autologous priming of the cardiopulmonary circuit, salvage of shed blood,
and tolerance of moderate hemodilution can be easily applied.</p><p>There are limitations in this study. Firstly, CVP and the erythrocyte transfusion
performed with strict indication were not modifiable, but they can be surrogate
markers, indicating pathophysiological status, which can be optimized before their
onset. Secondly, CSA-AKI was not identified with CIN in patients who underwent
catheterization before surgery because both pathophysiological courses overlap.
However, a short interval between catheterization and surgery shall not be
encouraged yet. Thirdly, this study derived from a single-center retrospective
observational study, and prospective randomized clinical trials are needed to verify
whether the modification of these modifiable risk factors can genuinely reduce the
incidence of AKI-RRT and improve prognosis.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In this study, we attempted to find modifiable risk factors in CSA-AKI patients and
aimed to prevent these patients from a continuous worsening renal function. To
exclude the influence of the confounder, we performed a propensity score match, and
several modifiable risk factors, including contrast exposure within 3 days before
surgery, erythrocyte transfusion, and ICU admission CVP, resulted to be the
predictors for AKI-RRT.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">WJ</td><td align="left" valign="top" rowspan="1" colspan="1">Analyzed the data, interpreted the results
and writing; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BS</td><td align="left" valign="top" rowspan="1" colspan="1">Analyzed the data; interpreted the results
and writing; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">YW</td><td align="left" valign="top" rowspan="1" colspan="1">Participated in data collection and
maintenance; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JX</td><td align="left" valign="top" rowspan="1" colspan="1">Analyzed the data; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ZL</td><td align="left" valign="top" rowspan="1" colspan="1">Participated in reviewing the manuscript;
final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">XD</td><td align="left" valign="top" rowspan="1" colspan="1">Designed and directed the study; final
approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JT</td><td align="left" valign="top" rowspan="1" colspan="1">Designed and directed the study; final
approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Zhongshan Hospital, Shanghai Medical College, Fudan
University, Shanghai, China.</p></fn><fn fn-type="financial-disclosure"><p><bold>Financial Support</bold></p><p>This study is funded by the Shanghai Clinical Medical Center for Kidney Disease
Project support by Shanghai Municipal Health Commission (No. 2017ZZ01015),
Shanghai Municipal Hospital Frontier Technology Project supported by Shanghai
ShenKang Hospital Development Center, (SHDC12018127) and the Science and
Technology Commission of Shanghai Municipality (14DZ2260200, the project of
Shanghai Key Laboratory of Kidney and Blood Purification).</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ack><title>ACKNOWLEDGEMENTS</title><p>We thank the study personnel from the Departments of Nephrology, Cardiac Surgery, and
Critical Care for persistent contribution to the maintenance of the cardiac surgery
database.</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>NJ</given-names></name><name><surname>Freemantle</surname><given-names>N</given-names></name><name><surname>Bonser</surname><given-names>RS</given-names></name><name><surname>Graham</surname><given-names>TR</given-names></name><name><surname>Mascaro</surname><given-names>J</given-names></name><name><surname>Rooney</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Subtle changes in renal function are associated with differences
in late survival following adult cardiac surgery</article-title><source>Eur J Cardiothorac Surg</source><year>2012</year><volume>41</volume><issue>4</issue><fpage>e38</fpage><lpage>e42</lpage><pub-id pub-id-type="pmid">22423081</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Teng</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Dynamic predictive scores for cardiac surgery-associated acute
kidney injury</article-title><source>J Am Heart Assoc</source><year>2016</year><volume>5</volume><issue>8</issue><!--<pub-id pub-id-type="pii">e003754</pub-id>--></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palomba</surname><given-names>H</given-names></name><name><surname>Castro</surname><given-names>I</given-names></name><name><surname>Neto</surname><given-names>AL</given-names></name><name><surname>Lage</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name></person-group><article-title>Acute kidney injury prediction following elective cardiac
surgery: AKICS Score</article-title><source>Kidney Int</source><year>2007</year><volume>72</volume><issue>5</issue><fpage>624</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">17622275</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakar</surname><given-names>CV</given-names></name><name><surname>Arrigain</surname><given-names>S</given-names></name><name><surname>Worley</surname><given-names>S</given-names></name><name><surname>Yared</surname><given-names>JP</given-names></name><name><surname>Paganini</surname><given-names>EP</given-names></name></person-group><article-title>A clinical score to predict acute renal failure after cardiac
surgery</article-title><source>J Am Soc Nephrol</source><year>2005</year><volume>16</volume><issue>1</issue><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">15563569</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>KP</given-names></name><name><surname>Cavender</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>M</given-names></name><name><surname>Mark</surname><given-names>RG</given-names></name><name><surname>Celi</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Peripheral edema, central venous pressure, and risk of aki in
critical illness</article-title><source>Clin J Am Soc Nephrol</source><year>2016</year><volume>11</volume><issue>4</issue><fpage>602</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">26787777</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>S</given-names></name><name><surname>Ko</surname><given-names>B</given-names></name><name><surname>Adabag</surname><given-names>S</given-names></name></person-group><article-title>Contrast-induced nephropathy and risk of acute kidney injury and
mortality after cardiac operations</article-title><source>Ann Thorac Surg</source><year>2012</year><volume>94</volume><issue>3</issue><fpage>772</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">22835553</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karim</surname><given-names>HM</given-names></name><name><surname>Yunus</surname><given-names>M</given-names></name><name><surname>Saikia</surname><given-names>MK</given-names></name><name><surname>Kalita</surname><given-names>JP</given-names></name><name><surname>Mandal</surname><given-names>M</given-names></name></person-group><article-title>Incidence and progression of cardiac surgery-associated acute
kidney injury and its relationship with bypass and cross clamp
time</article-title><source>Ann Card Anaesth</source><year>2017</year><volume>20</volume><issue>1</issue><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">28074790</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Postoperative fluid overload is a useful predictor of the
short-term outcome of renal replacement therapy for acute kidney injury
after cardiac surgery</article-title><source>Medicine (Baltimore)</source><year>2015</year><volume>94</volume><issue>33</issue><elocation-id>e1360</elocation-id><pub-id pub-id-type="pmid">26287422</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karkouti</surname><given-names>K</given-names></name><name><surname>Grocott</surname><given-names>HP</given-names></name><name><surname>Hall</surname><given-names>R</given-names></name><name><surname>Jessen</surname><given-names>ME</given-names></name><name><surname>Kruger</surname><given-names>C</given-names></name><name><surname>Lerner</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Interrelationship of preoperative anemia, intraoperative anemia,
and red blood cell transfusion as potentially modifiable risk factors for
acute kidney injury in cardiac surgery: a historical multicentre cohort
study</article-title><source>Can J Anaesth</source><year>2015</year><volume>62</volume><issue>4</issue><fpage>377</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">25537735</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Stevens</surname><given-names>LA</given-names></name><name><surname>Schmid</surname><given-names>CH</given-names></name><name><surname>Zhang</surname><given-names>YL</given-names></name><name><surname>Castro 3rd</surname><given-names>AF</given-names></name><name><surname>Feldman</surname><given-names>HI</given-names></name><etal/><collab>CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)</collab></person-group><article-title>A new equation to estimate glomerular filtration
rate</article-title><source>Ann Intern Med</source><year>2009</year><volume>150</volume><issue>9</issue><fpage>604</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">19414839</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><article-title>Practice Guidelines for blood component therapy: a report by the
American Society of Anesthesiologists Task Force on Blood Component
Therapy</article-title><source>Anesthesiology</source><year>1996</year><volume>84</volume><issue>3</issue><fpage>732</fpage><lpage>747</lpage><pub-id pub-id-type="pmid">8659805</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney
Injury Work Group</collab></person-group><article-title>KDIGO clinical practice guideline for acute kidney
injury</article-title><source>Kidney Inter</source><year>2012</year><volume>2</volume><issue>Suppl</issue><fpage>1</fpage><lpage>138</lpage></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>H</given-names></name><name><surname>Katz</surname><given-names>N</given-names></name><name><surname>Ariyanon</surname><given-names>W</given-names></name><name><surname>Blanca-Martos</surname><given-names>L</given-names></name><name><surname>Adybelli</surname><given-names>Z</given-names></name><name><surname>Giuliani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cardiac surgery-associated acute kidney injury</article-title><source>Cardiorenal Med</source><year>2013</year><volume>3</volume><issue>3</issue><fpage>178</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">24454314</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amini</surname><given-names>S</given-names></name><name><surname>Robabi</surname><given-names>HN</given-names></name><name><surname>Tashnizi</surname><given-names>MA</given-names></name><name><surname>Vakili</surname><given-names>V</given-names></name></person-group><article-title>Selenium, vitamin C and N-acetylcysteine do not reduce the risk
of acute kidney injury after off-pump CABG: a randomized clinical
trial</article-title><source>Braz J Cardiovasc Surg</source><year>2018</year><volume>33</volume><issue>2</issue><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">29898141</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrman</surname><given-names>DY</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name></person-group><article-title>Epidemiology and pathophysiology of cardiac surgery-associated
acute kidney injury</article-title><source>Curr Opin Anaesthesiol</source><year>2017</year><volume>30</volume><issue>1</issue><fpage>60</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">27820742</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickering</surname><given-names>JW</given-names></name><name><surname>James</surname><given-names>MT</given-names></name><name><surname>Palmer</surname><given-names>SC</given-names></name></person-group><article-title>Acute kidney injury and prognosis after cardiopulmonary bypass: a
meta-analysis of cohort studies</article-title><source>Am J Kidney Dis</source><year>2015</year><volume>65</volume><issue>2</issue><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">25445101</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega-Loubon</surname><given-names>C</given-names></name><name><surname>Fern&#x000e1;ndez-Molina</surname><given-names>M</given-names></name><name><surname>Carrascal-Hinojal</surname><given-names>Y</given-names></name><name><surname>Fulquet-Carreras</surname><given-names>E</given-names></name></person-group><article-title>Cardiac surgery-associated acute kidney injury</article-title><source>Ann Card Anaesth</source><year>2016</year><volume>19</volume><issue>4</issue><fpage>687</fpage><lpage>698</lpage><pub-id pub-id-type="pmid">27716701</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golshahi</surname><given-names>J</given-names></name><name><surname>Nasri</surname><given-names>H</given-names></name><name><surname>Gharipour</surname><given-names>M</given-names></name></person-group><article-title>Contrast-induced nephropathy: a literature review</article-title><source>J Nephropathol</source><year>2014</year><volume>3</volume><issue>2</issue><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">24772397</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranucci</surname><given-names>M</given-names></name><name><surname>Ballotta</surname><given-names>A</given-names></name><name><surname>Agnelli</surname><given-names>B</given-names></name><name><surname>Frigiola</surname><given-names>A</given-names></name><name><surname>Menicanti</surname><given-names>L</given-names></name><name><surname>Castelvecchio</surname><given-names>S</given-names></name><collab>Surgical and Clinical Outcome Research (SCORE) Group</collab></person-group><article-title>Acute kidney injury in patients undergoing cardiac surgery and
coronary angiography on the same day</article-title><source>Ann Thorac Surg</source><year>2013</year><volume>95</volume><issue>2</issue><fpage>513</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">23201106</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name><name><surname>Wojdyla</surname><given-names>D</given-names></name><name><surname>Harskamp</surname><given-names>R</given-names></name><name><surname>Southerland</surname><given-names>KW</given-names></name><name><surname>Ferguson</surname><given-names>TB</given-names></name><etal/></person-group><article-title>Central venous pressure after coronary artery bypass surgery:
does it predict postoperative mortality or renal failure?</article-title><source>J Crit Care</source><year>2014</year><volume>29</volume><issue>6</issue><fpage>1006</fpage><lpage>1010</lpage><pub-id pub-id-type="pmid">25035048</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raimundo</surname><given-names>M</given-names></name><name><surname>Crichton</surname><given-names>S</given-names></name><name><surname>Syed</surname><given-names>Y</given-names></name><name><surname>Martin</surname><given-names>JR</given-names></name><name><surname>Beale</surname><given-names>R</given-names></name><name><surname>Treacher</surname><given-names>D</given-names></name><etal/></person-group><article-title>Low systemic oxygen delivery and BP and risk of progression of
early AKI</article-title><source>Clin J Am Soc Nephrol</source><year>2015</year><volume>10</volume><issue>8</issue><fpage>1340</fpage><lpage>1349</lpage><pub-id pub-id-type="pmid">26209157</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname><given-names>M</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Story</surname><given-names>D</given-names></name><name><surname>Letis</surname><given-names>A</given-names></name><name><surname>Klemz</surname><given-names>K</given-names></name><name><surname>Matalanis</surname><given-names>G</given-names></name><etal/></person-group><article-title>Effect of mean arterial pressure, haemoglobin and blood
transfusion during cardiopulmonary bypass on post-operative acute kidney
injury</article-title><source>Nephrol Dial Transplant</source><year>2012</year><volume>27</volume><issue>1</issue><fpage>153</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">21677302</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karkouti</surname><given-names>K</given-names></name><name><surname>Wijeysundera</surname><given-names>DN</given-names></name><name><surname>Yau</surname><given-names>TM</given-names></name><name><surname>McCluskey</surname><given-names>SA</given-names></name><name><surname>Chan</surname><given-names>CT</given-names></name><name><surname>Wong</surname><given-names>PY</given-names></name><etal/></person-group><article-title>Advance targeted transfusion in anemic cardiac surgical patients
for kidney protection: an unblinded randomized pilot clinical
trial</article-title><source>Anesthesiology</source><year>2012</year><volume>116</volume><issue>3</issue><fpage>613</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">22354243</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luten</surname><given-names>M</given-names></name><name><surname>Roerdinkholder-Stoelwinder</surname><given-names>B</given-names></name><name><surname>Schaap</surname><given-names>NP</given-names></name><name><surname>Grip</surname><given-names>WJ</given-names></name><name><surname>Bos</surname><given-names>HJ</given-names></name><name><surname>Bosman</surname><given-names>GJ</given-names></name></person-group><article-title>Survival of red blood cells after transfusion: a comparison
between red cells concentrates of different storage periods</article-title><source>Transfusion</source><year>2008</year><volume>48</volume><issue>7</issue><fpage>1478</fpage><lpage>1485</lpage><pub-id pub-id-type="pmid">18482180</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kocogullari</surname><given-names>CU</given-names></name><name><surname>Kunt</surname><given-names>AT</given-names></name><name><surname>Aksoy</surname><given-names>R</given-names></name><name><surname>Duzyol</surname><given-names>C</given-names></name><name><surname>Parlar</surname><given-names>H</given-names></name><name><surname>Saskin</surname><given-names>H</given-names></name><etal/></person-group><article-title>Hemoglobin A1c levels predicts acute kidney injury after coronary
artery bypass surgery in non-diabetic patients</article-title><source>Braz J Cardiovasc Surg</source><year>2017</year><volume>32</volume><issue>2</issue><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">28492788</pub-id></element-citation></ref></ref-list></back></article>